| J9271 | Injection, pembrolizumab, 1 mg | 5,200 | $40 | $213.2K |
| J0897 | Injection, denosumab, 1 mg | 3,600 | $20 | $64.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $120 | $25.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 320 | $70 | $23.4K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 280 | $80 | $21.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 160 | $60 | $9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $140 | $7.4K |
| J0185 | Injection, aprepitant, 1 mg | 4,810 | $1 | $4.8K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 70 | $60 | $4.3K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 300 | $10 | $4.2K |